Revumenib: the breakthrough pill curing leukemia in a third of patients
Patients with terminal leukemia who were not responding to treatment now have hope for a cure thanks to revumenib, a new experimental medication. In a long-awaited clinical trial in the United States, this medicine fully eradicated cancer in one-third of individuals. Although not all patients Read More...